Search

Displaying results 3131 - 3140 of 7063 in total
  1. Drug

    Saxagliptin

    go.drugbank.com/drugs/DB06335
    ApprovedInvestigational

    FDA approved on July 31, 2009.

  2. Drug

    Calcium glubionate anhydrous

    go.drugbank.com/drugs/DB13142
    Approved

    Calcium glubionate (or glubionate calcium) is a mineral supplement to prevent or treat low blood calcium levels in people who do not get enough calcium from their diets.

    Synonyms: (D-gluconato)(lactobionato)calcium, Calcium D-gluconate lactobionate
  3. Drug

    Letrozole

    go.drugbank.com/drugs/DB01006
    ApprovedInvestigational

    [A190546] Letrozole was granted FDA approval on 25 July 1997.[L11623] … [A190543,A1559,L11623,L11626] It is a third generation aromatase inhibitor like [exemestane] and [anastrozole], meaning it does not significantly affect cortisol, aldosterone, and thyroxine.

    Products: LETROZOL 1A PHARMA 2.5MG, LETROZOLO DOC GENERICI
  4. Drug

    Cetuximab

    go.drugbank.com/drugs/DB00002
    ApprovedInvestigational

    colorectal cancer with a BRAF V600E mutation. … [A227963] EGFR is often mutated in certain types of cancer and serves as a driver of tumorigenesis.

  5. Drug

    Bempedoic acid

    go.drugbank.com/drugs/DB11936
    ApprovedInvestigational

    [L12180] Bempedoic acid is first-in-class adenosine triphosphate-citrate lyase (ACL) inhibitor used once a day for reducing LDL cholesterol levels in statin-refractory patients. … High levels of LDL cholesterol (LDL-C) are a major risk factor for cardiovascular events.

  6. Drug

    Urokinase

    go.drugbank.com/drugs/DB00013
    ApprovedInvestigationalWithdrawn

    [A191943] Urokinase remains connected between these 2 chains by a sulfhydryl bond.[A191943] Urokinase was granted FDA approval on 16 January 1978.[L12138]

  7. Drug

    Dofetilide

    go.drugbank.com/drugs/DB00204
    ApprovedInvestigational

    Dofetilide is a class III antiarrhythmic agent that is approved by the Food and Drug Administration (FDA) for the maintenance of sinus rhythm in individuals prone to the formation of atrial fibrillation

    Categories: OCT2 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  8. Drug

    Cabamiquine

    go.drugbank.com/drugs/DB21477
    Investigational

    Cabamiquine has a monoisotopic molecular weight of 462.24 Da. … Cabamiquine is a small molecule drug.

  9. Drug

    Elunonavir

    go.drugbank.com/drugs/DB21518
    Experimental

    Elunonavir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Elunonavir is a antiviral. Elunonavir has a monoisotopic molecular weight of 1155.44 Da.

  10. Drug

    Trecadrine

    go.drugbank.com/drugs/DB19785
    Experimental

    Trecadrine is a small molecule drug. The usage of the INN stem '-drine' in the name indicates that Trecadrine is a sympathomimetic. Trecadrine has a monoisotopic molecular weight of 383.22 Da.